SCHEMBL3221267

SCHEMBL3221267

CN1CCN(c2cccc(Cl)c2)c2ccc(-c3cccnn3)cc2C1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 3/20 0.48
SLC6A2 P23975 7/20 0.43
SLC6A3 Q01959 7/20 0.43
SLC6A4 P31645 6/20 0.42
DRD2 P14416 2/20 0.41
DRD3 P35462 2/20 0.41
KCNH2 Q12809 2/20 0.41
DHFR P00374 1/20 0.39
GAA P10253 2/20 0.36
LMNA P02545 1/20 0.36
HRH4 Q9H3N8 1/20 0.36
DRD4 P21917 1/20 0.36
HTR2A P28223 1/20 0.36
AVPR1A P37288 1/20 0.35
ALDH1A1 P00352 1/20 0.35
MAPT P10636 1/20 0.35
TSHR P16473 1/20 0.35
HTT P42858 1/20 0.35
BCL2A1 Q16548 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3230176 0.89 SCN9A (0.49) SCN9ASLC6A2SLC6A3SLC6A4DHFR
SCHEMBL3232364 0.88 SCN9A (0.49) SCN9ASLC6A2SLC6A3SLC6A4DHFR
SCHEMBL3230988 0.88 SLC6A2 (0.48) SCN9ASLC6A2SLC6A3SLC6A4DRD2
SCHEMBL3221969 0.88 SCN9A (0.48) SCN9ASLC6A2SLC6A3SLC6A4DHFR
SCHEMBL3231467 0.86 SCN9A (0.48) SCN9ADRD2DRD3KCNH2DHFR
SCHEMBL3233754 0.85 SCN9A (0.48) SCN9ASLC6A2SLC6A3SLC6A4DHFR
SCHEMBL3239378 0.85 SCN9A (0.46) SCN9ASLC6A2SLC6A3SLC6A4DRD2
SCHEMBL3230497 0.85 SCN9A (0.48) SCN9ASLC6A2SLC6A3SLC6A4DRD2
SCHEMBL3231978 0.85 SCN9A (0.44) SCN9ASLC6A2SLC6A3SLC6A4DRD2
SCHEMBL3479760 0.85 SCN9A (0.57) SCN9ASLC6A2SLC6A3SLC6A4DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9096546-B2 Aryl- and heteroaryl-substituted tetrahydrobenzo-1,4-diazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin ALBANY MOLECULAR RESEARCH, INC. (US) 2015-08-04 US claimed
US-9096546-B2 Aryl- and heteroaryl-substituted tetrahydrobenzo-1,4-diazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin ALBANY MOLECULAR RESEARCH, INC. (US) 2015-08-04 US disclosed
US-20100137287-A1 ARYL-AND HETEROARYL-SUBSTITUTED TETRAHYDROBENZO-1,4-DIAZEPINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN ALBANY MOLECULAR RESEARCH, INC. (US) 2010-06-03 US disclosed
EP-2146722-A1 ARYL- AND HETEROARYL-SUBSTITUTED TETRAHYDROBENZO-1,4-DIAZEPINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN AMR Technology, Inc. (US) 2010-01-27 EP disclosed
WO-2008141081-A1 ARYL- AND HETEROARYL-SUBSTITUTED TETRAHYDROBENZO-1,4-DIAZEPINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN AMR TECHNOLOGY, INC. (US) 2008-11-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100137287-A1 ARYL-AND HETEROARYL-SUBSTITUTED TETRAHYDROBENZO-1,4-DIAZEPINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN ADRA1B, ADRB1, ADRA1D SCN9A 795/4885SLC6A2 28/4885SLC6A3 32/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.